TY - JOUR
T1 - The Role of Mitochondrial DNA Variation in Age-Related Decline in Gait Speed among Older Men Living with Human Immunodeficiency Virus
AU - Sun, Jing
AU - Brown, Todd T.
AU - Samuels, David C.
AU - Hulgan, Todd
AU - D'Souza, Gypsyamber
AU - Jamieson, Beth D.
AU - Erlandson, Kristine M.
AU - Martinson, Jeremy
AU - Palella, Frank J.
AU - Margolick, Joseph B.
AU - Kirk, Gregory D.
AU - Schrack, Jennifer A.
N1 - Funding Information:
Financial support. Data were collected by the Multicenter AIDS Cohort Study (MACS) with centers at Baltimore (U01-AI35042), the Johns Hopkins University Bloomberg School of Public Health: Joseph B. Margolick (principal investigator [PI]), Jay Bream, Todd Brown, Adrian Dobs, Michelle Estrella, W. David Hardy, Lisette Johnson-Hill, Sean Leng, Anne Monroe, Cynthia Munro, Michael W. Plankey, Wendy Post, Ned Sacktor, Jennifer Schrack, Chloe Thio; Chicago (U01-AI35039), Feinberg School of Medicine, Northwestern University, and Cook County Bureau of Health Services: Steven M. Wolinsky (PI), Sheila Badri, Dana Gabuzda, Frank J. Palella, Jr., Sudhir Penugonda, John P. Phair, Susheel Reddy, Matthew Stephens, Linda Teplin; Los Angeles (U01-AI35040), University of California–Los Angeles Schools of Public Health and Medicine: Roger Detels (PI), Otoniel Martínez-Maza (PI), Peter Anton, Robert Bolan, Elizabeth Breen, Anthony Butch, Shehnaz Hussain, Beth Jamieson, John Oishi, Harry Vinters, Dorothy Wiley, Mallory Witt, Otto Yang, Stephen Young, Zuo Feng Zhang; Pittsburgh (U01-AI35041), University of Pittsburgh, Graduate School of Public Health: Charles R. Rinaldo (PI), James T. Becker, Phalguni Gupta, Kenneth Ho, Lawrence A. Kingsley, Susan Koletar, Jeremy J. Martinson, John W. Mellors, Anthony J. Silvestre, Ronald D. Stall; Data Coordinating Center (UM1-AI35043), the Johns Hopkins University Bloomberg School of Public Health: Lisa P. Jacobson (PI), Gypsyamber D’Souza (PI), Alison Abraham, Keri Althoff, Michael Collaco, Priya Duggal, Sabina Haberlen, Eithne Keelaghan, Heather McKay, Alvaro Muñoz, Derek Ng, Anne Rostich, Eric C. Seaberg, Sol Su, Pamela Surkan, Nicholas Wada; Institute of Allergy and Infectious Diseases: Robin E. Huebner; National Cancer Institute: Geraldina Dominguez. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional cofunding from the National Cancer Institute, the National Institute on Drug Abuse, and the National Institute of Mental Health. Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute and the National Institute on Deafness and Communication Disorders. MACS data collection is also supported by UL1-TR001079 (Johns Hopkins Institute for Clinical and Translational Research, JHU ICTR) from the NCATS, a component of the NIH, and NIH Roadmap for Medical Research. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the NIH, Johns Hopkins ICTR, or NCATS. The MACS website is located at http:// aidscohortstudy.org/. J. A. S. was supported by K01AG048765 from NIA. T. T. B. was supported in part by R01AI093520 and K24AI120834 from the NIAID. K. M. E. was supported in part by K23AG050260 and R01AG054366 from the NIA. This work was also supported by the JHU Center for AIDS Research (1P30AI094189). Mitochondrial DNA haplogrouping in MACS was supported by R21DK101342 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to Hulgan and Brown.
Funding Information:
Potential conflicts of interest. T. H. and T. T. B. report grants from NIH/ NIDDK during the conduct of the study. K. E reports grants from NIH, Gilead, and Merck; nonfinancial support from Theratechnologies; and personal fees from EMD Serono, though not directly related to the submitted work. F. J. P. reports grants and personal fees from Gllead Sciences, Janssen, Merck, and ViiV, though not directly related to the submitted work. All remaining authors: No reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
Funding Information:
Acknowledgments. We acknowledge support from the multicenter AIDS cohort data coordinating center. We also acknowledge support for statistical consultation from the National Center for Research Resources and the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH) (grant 1UL1TR001079).
Publisher Copyright:
© Oxford University Press.
PY - 2018/8/16
Y1 - 2018/8/16
N2 - Background. Age-related gait speed decline is accelerated in men with human immunodeficiency virus (HIV). Mitochondrial genetic variation is associated with frailty and mortality in the general population and may provide insight into mechanisms of functional decline in people aging with HIV. Methods. Gait speed was assessed semiannually in the Multicenter AIDS Cohort Study. Mitochondrial DNA (mtDNA) haplogroups were extracted from genome-wide genotyping data, classifying men aged =50 years into 5 groups: mtDNA haplogroup H, J, T, Uk, and other. Differences in gait speed by haplogroups were assessed as rate of gait speed decline per year, probability of slow gait speed (<1.0 m/s), and hazard of slow gait using multivariable linear mixed-effects models, mixed-effects logistic regression models, and the Andersen-Gill model, controlling for hepatitis C virus infection, previous AIDS diagnosis, thymidine analogues exposure, education, body composition, smoking, and peripheral neuropathy. Age was further controlled for in the mixed-effects logistic regression models. Results. A total of 455 HIV-positive white men aged =50 years contributed 3283 person-years of follow-up. Among them, 70% had achieved HIV viral suppression. In fully adjusted models, individuals with haplogroup J had more rapid decline in gait speed (adjusted slopes, 0.018 m/s/year vs 0.011 m/s/year, pinteraction = 0.012) and increased risk of developing slow gait (adjusted odds ratio, 2.97; 95% confidence interval, 1.24-7.08) compared to those with other haplogroups. Conclusions. Among older, HIV-infected men, mtDNA haplogroup J was an independent risk factor for more rapid age-related gait speed decline.
AB - Background. Age-related gait speed decline is accelerated in men with human immunodeficiency virus (HIV). Mitochondrial genetic variation is associated with frailty and mortality in the general population and may provide insight into mechanisms of functional decline in people aging with HIV. Methods. Gait speed was assessed semiannually in the Multicenter AIDS Cohort Study. Mitochondrial DNA (mtDNA) haplogroups were extracted from genome-wide genotyping data, classifying men aged =50 years into 5 groups: mtDNA haplogroup H, J, T, Uk, and other. Differences in gait speed by haplogroups were assessed as rate of gait speed decline per year, probability of slow gait speed (<1.0 m/s), and hazard of slow gait using multivariable linear mixed-effects models, mixed-effects logistic regression models, and the Andersen-Gill model, controlling for hepatitis C virus infection, previous AIDS diagnosis, thymidine analogues exposure, education, body composition, smoking, and peripheral neuropathy. Age was further controlled for in the mixed-effects logistic regression models. Results. A total of 455 HIV-positive white men aged =50 years contributed 3283 person-years of follow-up. Among them, 70% had achieved HIV viral suppression. In fully adjusted models, individuals with haplogroup J had more rapid decline in gait speed (adjusted slopes, 0.018 m/s/year vs 0.011 m/s/year, pinteraction = 0.012) and increased risk of developing slow gait (adjusted odds ratio, 2.97; 95% confidence interval, 1.24-7.08) compared to those with other haplogroups. Conclusions. Among older, HIV-infected men, mtDNA haplogroup J was an independent risk factor for more rapid age-related gait speed decline.
KW - HIV
KW - aging
KW - gait speed.
KW - mitochondrial genetic
UR - http://www.scopus.com/inward/record.url?scp=85054979929&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054979929&partnerID=8YFLogxK
U2 - 10.1093/cid/ciy151
DO - 10.1093/cid/ciy151
M3 - Article
C2 - 29481608
AN - SCOPUS:85054979929
SN - 1058-4838
VL - 67
SP - 778
EP - 784
JO - Clinical Infectious Diseases
JF - Clinical Infectious Diseases
IS - 5
ER -